Alpine Investment Management Lowered Its Johnson & Johnson (JNJ) Holding; Fortuna Silver Mines Inc. (TSE:FVI) Had 4 Bullish Analysts

June 14, 2018 - By Peter Erickson

Fortuna Silver Mines Inc. (TSE:FVI) Logo

Alpine Investment Management Llc decreased Johnson & Johnson (JNJ) stake by 3.82% reported in 2018Q1 SEC filing. Alpine Investment Management Llc sold 31,069 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Alpine Investment Management Llc holds 782,562 shares with $100.29 million value, down from 813,631 last quarter. Johnson & Johnson now has $328.15 billion valuation. The stock decreased 0.23% or $0.28 during the last trading session, reaching $122.35. About 2.29M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 14, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: ; 27/03/2018 – Johnson & Johnson CDS Widens 5 Bps, Most in 23 Months; 17/04/2018 – JNJ RESTRUCTURING DRIVEN BY NEW TECHNOLOGY FOR NEWER PRODUCTS; 17/04/2018 – Johnson & Johnson Raises Sales Outlook; 05/04/2018 – JOHNSON & JOHNSON JNJ.N , IMERYS SA IMTP.PA ORDERED TO PAY $37 MLN IN NEW JERSEY CASE BLAMING TALC ON MESOTHELIOMA -COURTROOM VIDEO; 16/03/2018 – J&J says offered $2.1 bln for Lifescan diabetes business; 17/04/2018 – J&J SEES FY ADJ EPS $8.00 TO $8.20, EST. $8.10; 16/04/2018 – THE JANSSEN PHARMACEUTICAL COMPANIES – ENTERED WORLDWIDE COLLABORATION WITH BRISTOL-MYERS TO DEVELOP, COMMERCIALIZE FACTOR XIA INHIBITORS; 16/04/2018 – JANSSEN – UNDER AGREEMENT, CO, BRISTOL-MYERS SQUIBB TO ADVANCE BMS-986177 INTO PHASE 2 CLINICAL TRIALS; 15/03/2018 – JNJ ERDAFITINIB DESIGNATION FOR METASTATIC UROTHELIAL CANCER; 16/03/2018 – J&J – DEAL FOR APPROXIMATELY $2.1 BLN,

Among 5 analysts covering Fortuna Silver Mines Inc. (TSE:FVI), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Fortuna Silver Mines Inc. had 22 analyst reports since August 11, 2015 according to SRatingsIntel. The company was maintained on Friday, March 31 by BMO Capital Markets. The stock of Fortuna Silver Mines Inc. (TSE:FVI) earned “Sector Outperformer” rating by IBC on Thursday, October 8. Canaccord Genuity upgraded it to “Buy” rating and $11.50 target in Monday, October 24 report. Raymond James maintained it with “Strong Buy” rating and $10 target in Wednesday, April 19 report. As per Thursday, January 12, the company rating was maintained by Scotia Capital. The company was maintained on Friday, November 17 by BMO Capital Markets. The stock has “Sector Perform” rating by Scotia Capital on Thursday, March 23. See Fortuna Silver Mines Inc. (TSE:FVI) latest ratings:

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. Shares for $20.17 million were sold by Stoffels Paulus on Thursday, February 15.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 earnings per share, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53 billion for 14.85 P/E if the $2.06 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Alpine Investment Management Llc increased Dell Technologies Inc stake by 10,057 shares to 20,792 valued at $1.52 million in 2018Q1. It also upped Goldman Sachs Etf Tr stake by 130,585 shares and now owns 5.21 million shares. General Mtrs Co (NYSE:GM) was raised too.

Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It increased, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Regentatlantic Cap stated it has 179,885 shares. Buckhead Management Limited Co owns 74,542 shares for 2.11% of their portfolio. Transamerica Fincl Advsr Inc holds 54,611 shares. Hermes Ltd reported 0.07% in Johnson & Johnson (NYSE:JNJ). Schwartz Counsel holds 1.58% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 747,154 shares. Academy Cap Management Tx holds 3.53% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 99,314 shares. Integral Derivatives Ltd Liability Co reported 13,981 shares. Mngmt Of Virginia holds 0.83% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 27,935 shares. New Mexico Educational Retirement Board invested in 256,043 shares. Newfocus Group Ltd Liability Company has 2.62% invested in Johnson & Johnson (NYSE:JNJ) for 32,599 shares. Clark Cap Group Inc invested in 299,634 shares. River & Mercantile Asset Ltd Liability Partnership invested in 0.58% or 38,450 shares. Sumitomo Mitsui Asset Management holds 0.48% in Johnson & Johnson (NYSE:JNJ) or 254,742 shares. Needelman Asset Incorporated holds 2.85% or 10,310 shares in its portfolio. State Of Tennessee Treasury Department invested 0.99% in Johnson & Johnson (NYSE:JNJ).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Recent Purchase: Johnson & Johnson” on June 14, 2018, also with their article: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” published on June 12, 2018, published: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” on June 01, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “Better Buy: Verizon Communications Inc. vs. Johnson & Johnson” published on June 11, 2018 as well as‘s news article titled: “Many Large US Firms Sell, Hire And Invest More Overseas Than In US And They Have To Think Globally, Not …” with publication date: June 14, 2018.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, January 12 by Wells Fargo. The firm earned “Overweight” rating on Wednesday, April 20 by Barclays Capital. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, August 25. Cowen & Co has “Outperform” rating and $114 target. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Friday, June 2 by BMO Capital Markets. Alembic downgraded the stock to “Underweight” rating in Friday, July 21 report. Barclays Capital maintained the stock with “Equal-Weight” rating in Wednesday, October 18 report. The stock has “Buy” rating by BMO Capital Markets on Tuesday, July 18. The firm earned “Hold” rating on Wednesday, April 6 by Societe Generale. BTIG Research maintained the stock with “Sell” rating in Wednesday, August 2 report. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, January 25.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: